CAS number：1014691-61-2 molecular formula：C19H18N2O5S2
product description： GSK0660 has antiangiogenic property in oxygen-induced retinopathy. It also regulates tumor necrosis factor-α (TNFα)-induced inflammation in human retinal microvascular endothelial cells (HRMECs). application： GSK0660 has been used to study the effects of bezafibrate (BZA) on hypertrophy.
| Chinese alias | - | ||
| English alias | SCHEMBL14970321 | methyl 3-(N-(2-methoxy-4-(phenylamino)phenyl)sulfamoyl)thiophene-2-carboxylate | HMS3413N06 | L-terpinen-4-ol | BDBM50383373 | DTXSID10673163 | AM81226 | AC-31444 | AKOS024457626 | Tox21_201720 | CHEBI:94813 | MFCD12828770 | GSK0660 | GS | ||
| CAS number | 1014691-61-2 | molecular formula | C19H18N2O5S2 |
| molecular weight | 418.49 g/mol | Exact mass | - |
| PSA | 130.000 Ų | logp | 3.800 |
No numbering system information yet
No physical and chemical property information yet
No production method and use information yet
No upstream information yet
No downstream information yet
